Antigen presentation by endothelium: heparin reduces the immunogenicity of interferon-γ-treated endothelial cells
Authors:
- David A RixDRDavid A Rix
- John A KirbyJKJohn A Kirby
- 1 September 1997
- journal article
- research article
- Published by Elsevier in Transplant Immunology
- Vol. 5 (3) , 233-235
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Examination of the mechanism by which heparin antagonizes activation of a model endothelium by interferon-gamma (IFN-γ)Clinical and Experimental Immunology, 1997
- Immunogenicity of Biliary Epithelium: Investigation of Antigen Presentation to Cd4+ T CellsHepatology, 1996
- Role of glycosaminoglycans (GAGs) in regulation of the immunogenicity of human vascular endothelial cellsClinical and Experimental Immunology, 1996
- CAN GRAFT ENDOTHELIAL CELLS INITIATE A HOST ANTI-GRAFT IMMUNE RESPONSE?1Transplantation, 1996
- Heparin inhibits the antiparasitic and immune modulatory effects of human recombinant interferon-γEuropean Journal of Immunology, 1995
- ALLOPROLIFERATIVE RESPONSES OF PURIFIED CD4+ AND CD8+ T CELLS TO ENDOTHELIAL CELLS IN THE ABSENCE OF CONTAMINATING ACCESSORY CELLSTransplantation, 1994
- Application of an immortalized human endothelial cell line to the leucocyte: endothelial adherence assayJournal of Immunological Methods, 1993
- Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926In Vitro Cellular & Developmental Biology, 1990
- Human Endothelial Cells: Use of Heparin in Cloning and Long-Term Serial CultivationScience, 1983
- Permanent cell line expressing human factor VIII-related antigen established by hybridization.Proceedings of the National Academy of Sciences, 1983